World
2021.10.16 02:07 GMT+8

U.S. FDA advisers vote in favor of booster for J&J COVID-19 jab

Updated 2021.10.16 02:07 GMT+8
CGTN

A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose. /Getty Images

A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.

(With input from agencies)

Copyright © 

RELATED STORIES